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Abstract
Background: Neuromuscular electrostimulation has become a promising issue in cardiovascular rehabilitation.
However there are few articles published in the literature regarding neuromuscular electrostimulation in patients
with heart failure during hospital stay.
Methods: This is a randomized controlled pilot trial that aimed to investigate the effect of neuromuscular
electrostimulation in the walked distance by the six-minute walking test in 30 patients admitted to ward for heart
failure treatment in a tertiary cardiology hospital. Patients in the intervention group performed a conventional
rehabilitation and neuromuscular electrostimulation. Patients underwent 60 minutes of electrostimulation (wave
frequency was 20 Hz, pulse duration of 20 us) two times a day for consecutive days until hospital discharge.
Results: The walked distance in the six-minute walking test improved 75% in the electrostimulation group (from
379.7 ± 43.5 to 372.9 ± 46.9 meters to controls and from 372.9 ± 62.4 to 500 ± 68 meters to electrostimulation,
p<0.001). On the other hand, the walked distance in the control group did not change.
Conclusion: The neuromuscular electrostimulation group showed greater improvement in the walked distance in
the six-minute walking test in patients admitted to ward for compensation of heart failure.
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Background
Heart failure is the last stage of heart diseases and a sig-
nificant cause of worldwide mortality and morbidity [1].
It is characterized by exercise intolerance, [2] high mor-
tality [3] and poor quality of life [4].
Exercise training is considered to be an important and
safe component of a heart failure rehabilitation program.
This therapy is endorsed by current guidelines, [5,6] and
patients who join an exercise training program are
expected to improve exercise capacity [7] and quality of
life [8].
Neuromuscular electrostimulation is largely used as an
alternative adjuvant tool of exercise training to treat
muscle atrophy secondary to disuse in healthy people
and in patients with neuromuscular disorders [9]. This
technique has become a promising issue in cardiovascu-
lar rehabilitation and a growing number of studies have
being released with good results.
Initial studies showed that neuromuscular electrosti-
mulation can improve peak oxygen consumption [10]
and fatigue tolerance in patients with heart failure [11].
It seems that the best indication of neuromuscular elec-
trostimulation is for those patients that cannot perform
the conventional rehabilitation [12]. However there are
no articles published in the literature regarding neuro-
muscular electrostimulation in patients with heart failure
during hospital stay.
The aim of this randomized controlled pilot trial was
to investigate the influence of neuromuscular electrosti-
mulation in the walked distance in the six-minute walk-
ing test of heart failure patients during hospital stay.
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Methods
Trial design
This is a randomized controlled pilot trial that aimed to
investigate the effects neuromuscular electrostimulation
in patients admitted to ward for treatment of decompen-
sated heart failure.
As soon as the physician authorized the patients to be
included in the protocol, one independent blinded inves-
tigator performed a six-minute walking test followed by
blood sample collection (blood venous gas analysis and
lactate). After initial assessment, patients were rando-
mized to neuromuscular electrostimulation or control
groups by a second investigator. Immediately before
hospital discharge, patients repeated the same assess-
ment protocol by the same blinded investigator.
Study population
We included patients with heart failure aged over 18
years, with left ventricular ejection fraction less than
45% (echocardiography) admitted to ward in a tertiary
cardiology hospital for treatment of decompensated
heart failure. The characteristics of the subjects and their
medication profiles at the inclusion are shown in Table 1.
Patients with New York Heart Association Functional
Class IV, previous experience with neuromuscular elec-
trostimulation, with fever, using vasoactive drugs, in pro-
gram for surgery and patients with osteopathic and
pulmonary function limitations such as osteoarthritis
and chronic obstructive pulmonary disease were
excluded from the study (Figure 1).
This protocol was approved by the Ethical Committee
of our institution. All patients provided informed con-
sent prior to participation.
End points
The primary endpoint of this study was the walked dis-
tance in the six-minute walking test. The secondary end-
points were venous blood lactate and venous saturation of
oxygen before and after neuromuscular electrostimulation.
Randomization
After providing written informed consent, patients were
randomized in a 1:1 ratio to electrostimulation or con-
trol. To guarantee concealment of the allocation list,
randomization was implemented through a Web-based
automated randomization system.
Blinding
Considering our intervention protocol, it was not possible
to blind the patients and/or the investigator who per-
formed the electrostimulation. However, the other investi-
gator who conducted the six-minute walking tests was
blinded.
Study interventions
Patients in the intervention group underwent a conven-
tional rehabilitation and neuromuscular electrostimula-
tion. Conventional rehabilitation consisted in respiratory,
lower and upper limbs exercises in a stand position (3x10
repetitions, “‘somewhat hard–hard’, between 11 and 13 on
the Borg scale).
Neuromuscular electrostimulation was applied by an
electrostimulator (Neurodim III, IBRAMED, Brazil) with
alternating, biphasic and symmetric currents with rect-
angular pulses. The carrier wave frequency was 20 Hz,
pulse duration of 200 us. The time of ascent and descent
of the current was 4 s and the time of contraction/relax-
ation was 20 s. Adhesive surface electrodes 5 cm in
diameter were used through 4 channels in rectus femoris
(2 channels in the right and 2 in the left leg).
Patients underwent 60 minutes of electrostimulation
two times a day (morning and afternoon) for consecutive
days until hospital discharge. Patients were instructed
not to perform rehabilitation exercises during the neuro-
muscular electrostimulation sessions.
Control group
The control group performed the same conventional re-
habilitation protocol as the intervention group, but the
electrostimulator device was turned off.
Table 1 Patient’s characterization and medication profile
Control Intervention
Etiology N (%)
Ischemic 04 (40%) 04 (40%)
Non Ischemic 06 (60%) 06 (60%)
NYHA functional class (%)
I 0 0
II 06 (60%) 06 (60%)
III 04 (40%) 04 (40%)
Sex (%)
Male 06 (60%) 06 (60%)
Female 04 (40%) 04 (40%)
Age (years, mean ±SD) 49,5±14,3 52,2±9
LVEF (%, mean ±SD) 38,2±8,8 37,6±6,9
Current medications:
Diuretics 10 (100%) 10 (100%)
Digitalis 05 (50%) 04 (40%)
Betablocker 10 (100%) 09 (90%)
Vasodilator 02 (20%) 04 (40%)
Ca2+channel blocker 01 (10%) 01 (10%)
Anti-arrhythmic 01 (10%) —
NYHA= New York Heart Association, LVEF= Left ventricular ejection fraction
(echo), ACE= Angiotensin Converting Enzyme.
de Araújo et al. Journal of Cardiothoracic Surgery 2012, 7:124 Page 2 of 5
http://www.cardiothoracicsurgery.org/content/7/1/124
Six-minute walking test
The six-minute walking test was performed following the
American Thoracic Society guidelines [13] in a 20-meters
corridor. The first test was performed after the medical
team’s authorization and the second test was performed
immediately before patient’s hospital discharge.
Blood lactate and venous oxygen saturation
A blood sample of 01 ml was collected in patient’s periph-
eral venous access from the catheter line immediately after
the six-minute walking test. Blood lactate and venous oxy-
gen saturation were analyzed through Roche OMNIW S
Blood Gas Analyzer (Roche Diagnostics, USA).
Statistical analysis
The results are shown as mean and standard deviation. To
evaluate the effects of the electrostimulation between both
groups, we used analysis of variance (ANOVA). Data was
analyzed using the Statistical Package for Social Sciences
for Windows, 11.5 (SPSS Inc, Chicago, Illinois, USA). Stat-
istical significance was defined as p < 0.05.
Results
Study participants
Between July 2011 and October 2011, 30 patients were en-
rolled in a tertiary cardiology hospital in Brazil. Ten
patients did not meet inclusion criteria (Two patients
needed vasoative drugs / intensive care unit, three had
fever, three arrhythmia and two patients underwent cardiac
surgery). Ten patients were allocated to electrostimulation
and ten to placebo groups and they all were analyzed for
the primary outcome (Figure 1). Our sample did not show
losses or exclusions after randomization. The baseline
characteristics were well balanced between the groups
(Table 1). The studied patients did not show any harms or
unintended effects, such as muscular pain. The average of
exercise sessions in the electrostimulation and control
groups was 16±3 and 15±4 days respectively.
Our primary end-point, the walked distance in the six-
minute walking test, showed a 75% of improvement in
the electrostimulation group (p<0.001) (Figure 2). On
the other hand, the walked distance in the control group
did not change (Table 2).
Our secondary end-points showed the same behavior
than the walked distance in the six-minute walking test.
Patients in the electrostimulation group decreased the
blood lactate in 34% and venous saturation of oxygen in
12% (p<0.001) (Table 2). The control group did not
show differences in the blood lactate and in venous sat-
uration of oxygen.
Discussion
The main finding of this randomized controlled pilot
trial was the improvement in the walked distance in the
six-minute walking test after neuromuscular electrosti-
mulation. Moreover, patients showed decrease in venous
oxygen saturation and in blood lactate.
The relationship between heart failure, muscle impair-
ment and low exercise capacity is well known in cardi-
ology. Neuromuscular electrostimulation is largely used
Figure 1 Participants flow through the study.
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to treat muscle atrophy secondary to disuse in healthy
people and in patients with neuromuscular disorders.9
Thus, neuromuscular electrostimulation has been pro-
posed as a promising adjuvant therapy to potentialize
the effects of exercise training in patients engaged in
cardiovascular rehabilitation programs. Nevertheless,
this therapy seems to be well indicated in patients with
major functional limitations who can not perform the
conventional physical exercise training program (such as
bedridden patients). [14] On the other hand, our pilot
study showed a large benefit of using neuromuscular
electrostimulation in patients admitted to ward that
were able to perform the conventional phase I rehabilita-
tion program.
Two previous studies used a similar electrostimulation
protocol as ours for outpatients with heart failure and
showed good results in the walked distance in the six-
minute walking test., [15,16] In the study Nuhr et al.,16
the walked distance was much greater, which suggests
that the duration of the electrostimulation protocol can
play an important role in cardiovascular rehabilitation.
A meta-analysis showed that patients with greater func-
tional limitation are the most benefited with neuromuscular
electrostimulation. On the other hand, our study showed
that patients with lower exercise intolerance also seem to
benefit from electrostimulation. The number of studies
that compare the effects of neuromuscular electrostimula-
tion in heart failure patients at different functional status
and perform the same protocol is very limited, making it
difficult to interpret the data.
Although our results are promising, we can not indicate
neuromuscular electrostimulation to all patients with
heart failure admitted to ward for treatment of decompen-
sated heart failure. Our study suggests a new discussion
about the indications of neuromuscular electrostimulation
in patients with heart failure, especially for those patients
admitted to ward. This adjunct therapy is relatively costly
and a wide investigation is needed to elucidate which
patients are most suitable to this treatment.
The main limitation of this pilot trial was the sample size.
However, our data is very consistence regarding the im-
provement of the walked distance in the six-minute walking
test with the use of neuromuscular electrostimulation.
Conclusion
The neuromuscular electrostimulation group showed a
greater improvement in the walked distance in the six-
minute walking test in comparison to the control group.
Moreover, the intervention group showed a greater de-
crease in venous oxygen saturation and in blood lactate.
Neuromuscular electrostimulation seems to be an import-
ant adjuvant therapy in a rehabilitation program for those
patients admitted in ward for treatment of decompensated
heart failure.
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